@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q64676731 rdfs:label "Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B"@en ;
    schema1:dateModified "2026-03-31T20:24:28+00:00"^^xsd:dateTime ;
    schema1:description "تجربة سريرية"@ar,
        "ensayu clínicu"@ast,
        "assaig clínic"@ca,
        "clinical trial"@en,
        "clinical trial"@en-ca,
        "clinical trial"@en-gb,
        "clinical trial"@en-us,
        "klinika studo"@eo,
        "ensayo clínico"@es,
        "essai clinique"@fr,
        "ensaio clínico"@gl,
        "կլինիկական փորձարկում"@hy,
        "studio clinico"@it,
        "治験"@ja,
        "임상시험"@ko,
        "klinisch onderzoek"@nl,
        "ensaio clínico"@pt,
        "ensaio clínico"@pt-br,
        "клиническое исследование"@ru,
        "klinické štúdie"@sk,
        "клінічне випробування"@uk,
        "thử nghiệm lâm sàng"@vi,
        "临床试验"@zh,
        "临床试验"@zh-hans,
        "臨床試驗"@zh-hant ;
    schema1:version 2476794061 ;
    wikibase:identifiers 1 ;
    wikibase:sitelinks 0 ;
    wikibase:statements 21 ;
    p:P1132 wds:Q64676731-82EFD633-3E50-4A79-A314-5FA84E0CC4CD ;
    p:P1476 wds:Q64676731-11491690-FD87-49D2-9F85-006EB08B2182 ;
    p:P17 wds:Q64676731-84D401B6-461F-48C6-877A-D223BB7416BB ;
    p:P2899 wds:Q64676731-45DD59EE-1EBD-4A4A-8CB6-107BBA8BAB2F ;
    p:P3098 wds:Q64676731-AA04791B-DA0D-44CB-80D7-B25990836C11 ;
    p:P31 wds:Q64676731-D54FC95B-44B7-4D45-B596-C09BA96A1371 ;
    p:P4844 wds:Q64676731-C12FA565-4BC6-4866-AFFC-D4754BF205A7 ;
    p:P580 wds:Q64676731-914E1F19-572B-4A17-BFC2-53810DBF3B2E ;
    p:P582 wds:Q64676731-7C629651-82E0-4F41-AD8D-04FDC5665DA6 ;
    p:P6099 wds:Q64676731-82A1704C-174F-4603-AC8E-03D6773D264E ;
    p:P6153 wds:Q64676731-730A6948-ACCF-442D-AE41-49163AF6F2EF,
        wds:Q64676731-7AE92331-E8C9-458C-BB53-ACAA94C9ABCA,
        wds:Q64676731-8479056B-A7AB-4D76-84EB-473C2EC925E0,
        wds:Q64676731-ABD9A15D-95CA-4D42-AB8C-ADF8ECE2439B,
        wds:Q64676731-E1EBF8C3-9E4D-4B52-9394-E3BEAC3EDD7B ;
    p:P8363 wds:Q64676731-B81C6CDF-EC3F-4834-A412-0D25BD8A697B ;
    p:P859 wds:Q64676731-99659F2D-6339-4FE1-9387-FFE306492F48 ;
    p:P921 wds:Q64676731-8FBF0A3C-5D5E-4FE4-B856-2556BD4CEE8E,
        wds:Q64676731-A2F6AC54-DD93-4BA3-8610-318C31066318,
        wds:Q64676731-D15C7840-99C9-41CB-A87F-45BC5E90A101,
        wds:Q64676731-E335D371-C3B9-4C49-AE25-5DCE56936AC7 ;
    wdt:P1132 148.0 ;
    wdt:P1476 "Entecavir and Peginterferon Alfa-2a Sequential Therapy Versus Peginterferon Alfa-2a Monotherapy for HBeAg Positive Chronic Hepatitis B"@en ;
    wdt:P17 wd:Q865 ;
    wdt:P2899 18.0 ;
    wdt:P3098 "NCT00921180" ;
    wdt:P31 wd:Q30612 ;
    wdt:P4844 wd:Q20817235 ;
    wdt:P580 "2007-02-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P582 "2013-12-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P6099 wd:Q42825046 ;
    wdt:P6153 wd:Q10882759,
        wd:Q1418766,
        wd:Q15901822,
        wd:Q30262812,
        wd:Q32746 ;
    wdt:P8363 wd:Q9164018 ;
    wdt:P859 wd:Q1418766 ;
    wdt:P921 wd:Q131742,
        wd:Q157661,
        wd:Q420056,
        wd:Q6853 .